Evidence map›Paper›PMID 41658317›Full record

ArticleAntimicrobial stewardship & healthcare epidemiology : ASHE2026

APSIC revised guidelines for prevention of central line associated bloodstream infections (CLABSI): a summary and position statement.

Moi Lin Ling, Anucha Apisarnthanarak, Patricia Ching, Yee-Chun Chen, Glenys Harrington, Jin-Won Huh, Namita Jaggi, Keita Morikane, Sahadol Poonyathawon

Abstract read
In one paragraph

Article in Antimicrobial stewardship & healthcare epidemiology : ASHE, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Moi Lin LingInfection Prevention and Epidemiology, Singapore General Hospital, Singapore, Singapore.ORCID https://orcid.org/0000-0002-7110-4398
Anucha ApisarnthanarakThammasat University Hospital, Thailand.
Patricia ChingThe University of Hong Kong School of Public Health, Hong Kong.
Yee-Chun ChenNational Taiwan University Hospital, Taiwan.
Glenys HarringtonInfection Control Consultancy, Australia.ORCID https://orcid.org/0009-0009-7898-3987
Jin-Won HuhUniversity of Ulsan College of Medicine, Republic of Korea.
Namita JaggiArtemis Hospitals, India.ORCID https://orcid.org/0000-0002-4319-0524
Keita MorikaneYamagata University Hospital, Japan.ORCID https://orcid.org/0000-0002-4215-7829
Sahadol PoonyathawonChulalongkorn University Faculty of Medicine, Thailand.ORCID https://orcid.org/0009-0004-0619-7542

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To describe the revised Asia Pacific Society of Infection Control (APSIC) Guidelines for Prevention of Central Line Associated Blood Stream Infections (CLABSI) 2024. Design: The revised guidelines was developed by infection prevention and control experts and key opinion leaders from Asia Pacific. Setting: Emphasis on practical implementation of Central Line Insertion and Maintenance Bundles using quality improvement approach is recommended towards the goal of achieving zero CLABSI in any healthcare setting. Patients or participants: Any patients with a central line in a healthcare setting. Interventions: Literature search was done for recent international updates in CLABSI prevention. Recommendations were evaluated for practical and feasible implementation in low resourced settings. Results: The key recommendations are listed in the APSIC CLABSI insertion and maintenance guidelines. Additional measures are recommended for use where CLABSI rates remain high despite implementation of all preventive strategies to achieve institutional goals. Conclusions: A surveillance program is recommended to monitor outcomes and compliance with bundles. Ongoing review of the performance data with appropriate interventions made should facilitate efforts towards zero CLABSI rate.

Identifiers

PMID41658317
PMCPMC12877909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.